argenx: Clinical Trials & Research Profile

Biopharma Industry (Global / Institutional) · Primary Focus: Rare Genetic, Women's Health, and Other

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Global / Institutional)
Primary Therapeutic AreaRare Genetic, Women's Health, and Other
Active Phase II & III Studies29 active (13 recruiting now)
Total Tracked Studies (2018 to 2026)54 (35 with California sites)
Completed vs Early-Stopped Studies17 completed / 8 stopped (14.8% stop rate)
Median Closed Enrollment103 participants
FDA Drugs@FDA Original Approvals0 all-time (0 from 2018 to 2026)
Physical Hospital Site Disclosure99.9% named hospital slots

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk